<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32803397</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers.</ArticleTitle><Pagination><StartPage>561</StartPage><EndPage>572</EndPage><MedlinePgn>561-572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-020-03619-3</ELocationID><Abstract><AbstractText>Extracellular vesicles (EVs) are small reservoirs of different molecules and important mediators of cell-to-cell communication. As putative vehicles of misfolded protein propagation between cells, they have drawn substantial attention in the field of amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. Moreover, exosome-mediated non-coding RNA delivery may play a crucial role in ALS, given the relevance of RNA homeostasis in disease pathogenesis. Since EVs can enter the systemic circulation and are easily detectable in patients' biological fluids, they have generated broad interest both as diagnostic and prognostic biomarkers and as valuable tools in understanding disease pathogenesis. Here, after a brief introduction on biogenesis and functions of EVs, we aim to investigate their role in neurodegenerative disorders, especially ALS. Specifically, we focus on the main findings supporting EV-mediated protein and RNA transmission in ALS in vitro and in vivo models. Then, we provide an overview of clinical applications of EVs, summarizing the most relevant studies able to detect EVs in blood and cerebrospinal fluid (CSF) of ALS patients, underlying their potential use in aiding diagnosis and prognosis. Finally, we explore the therapeutic applications of EVs in ALS, either as targets or as vehicles of proteins, nucleic acids and molecular drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Delia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bresolin</LastName><ForeName>Nereo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comi</LastName><ForeName>Giacomo Pietro</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corti</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5425-969X</Identifier><AffiliationInfo><Affiliation>Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy. stcorti@yahoo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy. stcorti@yahoo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF-2018-12366357</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="N">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Extracellular vesicles</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disorders</Keyword><Keyword MajorTopicYN="N">Prion-like properties</Keyword><Keyword MajorTopicYN="N">Therapeutics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32803397</ArticleId><ArticleId IdType="pmc">PMC7872995</ArticleId><ArticleId IdType="doi">10.1007/s00018-020-03619-3</ArticleId><ArticleId IdType="pii">10.1007/s00018-020-03619-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113:1&#x2013;11. doi: 10.1007/s11060-013-1084-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-013-1084-8</ArticleId><ArticleId IdType="pmc">PMC5533094</ArticleId><ArticleId IdType="pubmed">23456661</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364&#x2013;372. doi: 10.1016/j.tcb.2015.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.01.004</ArticleId><ArticleId IdType="pubmed">25683921</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto J, Stewart T, Banks WA, Zhang J. The transport mechanism of extracellular vesicles at the blood-brain barrier. Curr Pharm Des. 2017;23:6206&#x2013;6214. doi: 10.2174/1381612823666170913164738.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170913164738</ArticleId><ArticleId IdType="pubmed">28914201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015;77:13&#x2013;27. doi: 10.1146/annurev-physiol-021014-071641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-021014-071641</ArticleId><ArticleId IdType="pubmed">25293529</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocol Cell Biol. 2006;30:3.22.1&#x2013;3.22.29. doi: 10.1002/0471143030.cb0322s30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471143030.cb0322s30</ArticleId><ArticleId IdType="pubmed">18228490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai RC, Yeo RWY, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82&#x2013;88. doi: 10.1016/j.semcdb.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2015.03.001</ArticleId><ArticleId IdType="pubmed">25765629</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco V, Hannus M, Eaton S. Argosomes: a potential vehicle for the spread of morphogens through epithelia. Cell. 2001;106:633&#x2013;645. doi: 10.1016/S0092-8674(01)00484-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00484-6</ArticleId><ArticleId IdType="pubmed">11551510</ArticleId></ArticleIdList></Reference><Reference><Citation>Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014;306:C621&#x2013;C633. doi: 10.1152/ajpcell.00228.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00228.2013</ArticleId><ArticleId IdType="pubmed">24452373</ArticleId></ArticleIdList></Reference><Reference><Citation>An K, Klyubin I, Kim Y, et al. Exosomes neutralize synaptic-plasticity-disrupting activity of A&#x3b2; assemblies in vivo. Mol Brain. 2013;6:47. doi: 10.1186/1756-6606-6-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-47</ArticleId><ArticleId IdType="pmc">PMC4222117</ArticleId><ArticleId IdType="pubmed">24284042</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadi H, Ekstr&#xf6;m K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654&#x2013;659. doi: 10.1038/ncb1596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1596</ArticleId><ArticleId IdType="pubmed">17486113</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Bonetto V. Extracellular vesicles and a novel form of communication in the brain. Front Neurosci. 2016;10:127. doi: 10.3389/fnins.2016.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00127</ArticleId><ArticleId IdType="pmc">PMC4814526</ArticleId><ArticleId IdType="pubmed">27065789</ArticleId></ArticleIdList></Reference><Reference><Citation>Faur&#xe9; J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31:642&#x2013;648. doi: 10.1016/j.mcn.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.12.003</ArticleId><ArticleId IdType="pubmed">16446100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachenal G, Pernet-Gallay K, Chivet M, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci. 2011;46:409&#x2013;418. doi: 10.1016/j.mcn.2010.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2010.11.004</ArticleId><ArticleId IdType="pubmed">21111824</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci F, Turola E, Riganti L, et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J. 2012;31:1231&#x2013;1240. doi: 10.1038/emboj.2011.489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.489</ArticleId><ArticleId IdType="pmc">PMC3297996</ArticleId><ArticleId IdType="pubmed">22246184</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, Gray E, Heman-Ackah SM, et al. Extracellular vesicles in neurodegenerative disease&#x2014;pathogenesis to biomarkers. Nat Rev Neurol. 2016;12:346&#x2013;357. doi: 10.1038/nrneurol.2016.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.68</ArticleId><ArticleId IdType="pubmed">27174238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich D, Kuo WP, Fr&#xfc;hbeis C, et al. Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos Trans R Soc Lond B Biol Sci. 2014;369(1652):20130510. doi: 10.1098/rstb.2013.0510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2013.0510</ArticleId><ArticleId IdType="pmc">PMC4142031</ArticleId><ArticleId IdType="pubmed">25135971</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya R, Zingg W, Shetty S, Shetty AK. Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J Control Release. 2020 doi: 10.1016/j.jconrel.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7299747</ArticleId><ArticleId IdType="pubmed">32289328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin R-D, Meylan P, Decosterd I. Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation. Front Cell Neurosci. 2013;7:251. doi: 10.3389/fncel.2013.00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00251</ArticleId><ArticleId IdType="pmc">PMC3857901</ArticleId><ArticleId IdType="pubmed">24368897</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan E, Green J, Bodogai M, et al. Age-related changes in plasma extracellular vesicle characteristics and internalization by leukocytes. Sci Rep. 2017;7:1342. doi: 10.1038/s41598-017-01386-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01386-z</ArticleId><ArticleId IdType="pmc">PMC5430958</ArticleId><ArticleId IdType="pubmed">28465537</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 2010;33:317&#x2013;325. doi: 10.1016/j.tins.2010.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2010.04.003</ArticleId><ArticleId IdType="pubmed">20493564</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Selkoe DJ. A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci. 2016;17:251&#x2013;260. doi: 10.1038/nrn.2016.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.13</ArticleId><ArticleId IdType="pmc">PMC6701169</ArticleId><ArticleId IdType="pubmed">26988744</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Trojanowski JQ, Lee VM-Y. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16:199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalh&#xe3;es AC, Baron GS, Lee KS, et al. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci. 2005;25:5207&#x2013;5216. doi: 10.1523/JNEUROSCI.0653-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0653-05.2005</ArticleId><ArticleId IdType="pmc">PMC6724812</ArticleId><ArticleId IdType="pubmed">15917460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gousset K, Schiff E, Langevin C, et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol. 2009;11:328&#x2013;336. doi: 10.1038/ncb1841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1841</ArticleId><ArticleId IdType="pubmed">19198598</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H, Ikezu S, Tsunoda S, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18:1584&#x2013;1593. doi: 10.1038/nn.4132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4132</ArticleId><ArticleId IdType="pmc">PMC4694577</ArticleId><ArticleId IdType="pubmed">26436904</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmanouilidou E, Melachroinou K, Roumeliotis T, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30:6838&#x2013;6851. doi: 10.1523/JNEUROSCI.5699-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5699-09.2010</ArticleId><ArticleId IdType="pmc">PMC3842464</ArticleId><ArticleId IdType="pubmed">20484626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngolab J, Trinh I, Rockenstein E, et al. Brain-derived exosomes from dementia with Lewy bodies propagate &#x3b1;-synuclein pathology. Acta Neuropathol Commun. 2017;5:46. doi: 10.1186/s40478-017-0445-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0445-5</ArticleId><ArticleId IdType="pmc">PMC5466770</ArticleId><ArticleId IdType="pubmed">28599681</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gonzalez R, Gauthier SA, Kumar A, Levy E. The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem. 2012;287:43108&#x2013;43115. doi: 10.1074/jbc.M112.404467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.404467</ArticleId><ArticleId IdType="pmc">PMC3522305</ArticleId><ArticleId IdType="pubmed">23129776</ArticleId></ArticleIdList></Reference><Reference><Citation>Saman S, Kim W, Raya M, et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem. 2012;287:3842&#x2013;3849. doi: 10.1074/jbc.M111.277061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.277061</ArticleId><ArticleId IdType="pmc">PMC3281682</ArticleId><ArticleId IdType="pubmed">22057275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Liu C, Cook TJ, et al. Plasma exosomal &#x3b1;-synuclein is likely CNS-derived and increased in Parkinson&#x2019;s disease. Acta Neuropathol. 2014;128:639&#x2013;650. doi: 10.1007/s00401-014-1314-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1314-y</ArticleId><ArticleId IdType="pmc">PMC4201967</ArticleId><ArticleId IdType="pubmed">24997849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Balaji V, Kaniyappan S, et al. The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017;12(1):5. doi: 10.1186/s13024-016-0143-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0143-y</ArticleId><ArticleId IdType="pmc">PMC5237256</ArticleId><ArticleId IdType="pubmed">28086931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kfoury N, Holmes BB, Jiang H, et al. Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem. 2012;287:19440&#x2013;19451. doi: 10.1074/jbc.M112.346072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.346072</ArticleId><ArticleId IdType="pmc">PMC3365982</ArticleId><ArticleId IdType="pubmed">22461630</ArticleId></ArticleIdList></Reference><Reference><Citation>Garden GA, La Spada AR. Intercellular (mis)communication in neurodegenerative disease. Neuron. 2012;73:886&#x2013;901. doi: 10.1016/j.neuron.2012.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.02.017</ArticleId><ArticleId IdType="pmc">PMC3334539</ArticleId><ArticleId IdType="pubmed">22405200</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli RC, Bergamini G, Rajendran L. Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience. 2019;405:148&#x2013;157. doi: 10.1016/j.neuroscience.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.04.003</ArticleId><ArticleId IdType="pubmed">29660443</ArticleId></ArticleIdList></Reference><Reference><Citation>Prada I, Gabrielli M, Turola E, et al. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations. Acta Neuropathol. 2018;135:529&#x2013;550. doi: 10.1007/s00401-017-1803-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1803-x</ArticleId><ArticleId IdType="pmc">PMC5978931</ArticleId><ArticleId IdType="pubmed">29302779</ArticleId></ArticleIdList></Reference><Reference><Citation>Counil H, Krantic S. Synaptic activity and (neuro)inflammation in Alzheimer&#x2019;s disease: could exosomes be an additional link? J Alzheimers Dis. 2020;74:1029&#x2013;1043. doi: 10.3233/JAD-191237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-191237</ArticleId><ArticleId IdType="pubmed">32176642</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti B, Leggio L, L&#x2019;Episcopo F, et al. Glia-derived extracellular vesicles in Parkinson&#x2019;s disease. J Clin Med. 2020;9:1941. doi: 10.3390/jcm9061941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061941</ArticleId><ArticleId IdType="pmc">PMC7356371</ArticleId><ArticleId IdType="pubmed">32575923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Brandi J, Manfredi M, et al. The anti-apoptotic effect of ASC-exosomes in an in vitro ALS model and their proteomic analysis. Cells. 2019;8:1087. doi: 10.3390/cells8091087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091087</ArticleId><ArticleId IdType="pmc">PMC6770878</ArticleId><ArticleId IdType="pubmed">31540100</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Fernando SM, Grad LI, et al. Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol. 2016;36:377&#x2013;381. doi: 10.1007/s10571-015-0294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Br&#xe4;nnstr&#xf6;m T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Keller S, Altevogt P, Costa J. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett. 2007;428:43&#x2013;46. doi: 10.1016/j.neulet.2007.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.024</ArticleId><ArticleId IdType="pubmed">17942226</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Pozzi S, Tortarolo M, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288:15699&#x2013;15711. doi: 10.1074/jbc.M112.425066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, O&#x2019;Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Massenzio F, Pe&#xf1;a-Altamira E, Petralla S, et al. Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3771&#x2013;3785. doi: 10.1016/j.bbadis.2018.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.10.013</ArticleId><ArticleId IdType="pubmed">30315929</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Christy D, Shyu CC, et al. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem. 2019;294:3744&#x2013;3759. doi: 10.1074/jbc.RA118.004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang Y-J, Baker M, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Kametani F, Arai T, et al. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet. 2009;18:3353&#x2013;3364. doi: 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Ma M, Teng J, et al. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget. 2015;6:24178&#x2013;24191. doi: 10.18632/oncotarget.4680.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4680</ArticleId><ArticleId IdType="pmc">PMC4695178</ArticleId><ArticleId IdType="pubmed">26172304</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Steinacker P, Lehnert S, et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:351&#x2013;356. doi: 10.3109/21678421.2014.905606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.905606</ArticleId><ArticleId IdType="pubmed">24834468</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chen J, Kuang L, et al. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta Mol Basis Dis. 2016;1862:2004&#x2013;2014. doi: 10.1016/j.bbadis.2016.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.07.015</ArticleId><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, Bieniek KF, Gendron TF, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, et al. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S, Chapnik E, Sztainberg Y, et al. miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A. 2010;107:13111&#x2013;13116. doi: 10.1073/pnas.1006151107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006151107</ArticleId><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D, Comi GP, Bresolin N, Corti S. MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis. J Cell Mol Med. 2019;23:1647&#x2013;1656. doi: 10.1111/jcmm.13976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13976</ArticleId><ArticleId IdType="pmc">PMC6378226</ArticleId><ArticleId IdType="pubmed">30614179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T, Yamashita T, Tamaoka A, Kwak S. Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. Int J Mol Sci. 2019;20:3148. doi: 10.3390/ijms20133148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133148</ArticleId><ArticleId IdType="pmc">PMC6651127</ArticleId><ArticleId IdType="pubmed">31252669</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Cunha C, Barbosa M, et al. Exosomes from NSC-34 cells transfected with hSOD1-G93A are enriched in miR-124 and drive alterations in microglia phenotype. Front Neurosci. 2017;11:273. doi: 10.3389/fnins.2017.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00273</ArticleId><ArticleId IdType="pmc">PMC5434170</ArticleId><ArticleId IdType="pubmed">28567000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Guan Y, Chen Y, et al. miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice. Int J Clin Exp Pathol. 2013;6:1826&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759489</ArticleId><ArticleId IdType="pubmed">24040447</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L, Regan M, Higashimori H, et al. Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem. 2013;288:7105&#x2013;7116. doi: 10.1074/jbc.M112.410944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.410944</ArticleId><ArticleId IdType="pmc">PMC3591620</ArticleId><ArticleId IdType="pubmed">23364798</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, Gitler AD. Distinct repertoires of microRNAs present in mouse astrocytes compared to astrocyte-secreted exosomes. PLoS ONE. 2017;12:e0171418. doi: 10.1371/journal.pone.0171418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171418</ArticleId><ArticleId IdType="pmc">PMC5289606</ArticleId><ArticleId IdType="pubmed">28152040</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Zhao Y, Zhou X, et al. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D, Wajnberg G, Roy J, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M, Hama Y, Utsumi J, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2019;708:134176. doi: 10.1016/j.neulet.2019.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.048</ArticleId><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol. 2020;10:200116. doi: 10.1098/rsob.200116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200116</ArticleId><ArticleId IdType="pmc">PMC7333885</ArticleId><ArticleId IdType="pubmed">32574550</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and Glial activity. Front Neurosci. 2017;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sison SL, Patitucci TN, Seminary ER, et al. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Hum Mol Genet. 2017;26:3409&#x2013;3420. doi: 10.1093/hmg/ddx230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx230</ArticleId><ArticleId IdType="pubmed">28637335</ArticleId></ArticleIdList></Reference><Reference><Citation>Leidinger P, Backes C, Deutscher S, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14:R78. doi: 10.1186/gb-2013-14-7-r78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2013-14-7-r78</ArticleId><ArticleId IdType="pmc">PMC4053778</ArticleId><ArticleId IdType="pubmed">23895045</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos MCT, Barreto-Sanz MA, Correia BRS, et al. miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson&#x2019;s disease. Oncotarget. 2018;9:17455&#x2013;17465. doi: 10.18632/oncotarget.24736.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24736</ArticleId><ArticleId IdType="pmc">PMC5915128</ArticleId><ArticleId IdType="pubmed">29707120</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Otake K, Kamiguchi H, Hirozane Y. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. BMC Med Genomics. 2019;12:7. doi: 10.1186/s12920-019-0473-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-019-0473-z</ArticleId><ArticleId IdType="pmc">PMC6329125</ArticleId><ArticleId IdType="pubmed">30630471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D, Meneri M, Saccomanno D, et al. Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature. Int J Mol Sci. 2019;20(17):4152. doi: 10.3390/ijms20174152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174152</ArticleId><ArticleId IdType="pmc">PMC6747516</ArticleId><ArticleId IdType="pubmed">31450699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13:38. doi: 10.3389/fnmol.2020.00038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00038</ArticleId><ArticleId IdType="pmc">PMC7096580</ArticleId><ArticleId IdType="pubmed">32265650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, La Salvia S, Giannini M, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, La Salvia S, Colombo F, et al. Leukocyte derived microvesicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis patients. Front Neurosci. 2019;13:344. doi: 10.3389/fnins.2019.00344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00344</ArticleId><ArticleId IdType="pmc">PMC6476347</ArticleId><ArticleId IdType="pubmed">31037054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xia K, Chen L, Fan D. Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2019;13:574. doi: 10.3389/fnins.2019.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00574</ArticleId><ArticleId IdType="pmc">PMC6560167</ArticleId><ArticleId IdType="pubmed">31231184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, Doi H, Kurata Y, et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci Res. 2019 doi: 10.1016/j.neures.2019.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2019.10.010</ArticleId><ArticleId IdType="pubmed">31669371</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta S, Rajasingh S, Drosos N, et al. Exosomes: new molecular targets of diseases. Acta Pharmacol Sin. 2018;39:501&#x2013;513. doi: 10.1038/aps.2017.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.162</ArticleId><ArticleId IdType="pmc">PMC5888687</ArticleId><ArticleId IdType="pubmed">29219950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Verrilli MA, Caviedes A, Cabrera A, et al. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience. 2016;320:129&#x2013;139. doi: 10.1016/j.neuroscience.2016.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.01.061</ArticleId><ArticleId IdType="pubmed">26851773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Scambi I, Peroni D, et al. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res. 2016;340:150&#x2013;158. doi: 10.1016/j.yexcr.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.12.009</ArticleId><ArticleId IdType="pubmed">26708289</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria E, Scambi I, Bonafede R, et al. ASCs-exosomes recover coupling efficiency and mitochondrial membrane potential in an in vitro model of ALS. Front Neurosci. 2019;13:1070. doi: 10.3389/fnins.2019.01070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01070</ArticleId><ArticleId IdType="pmc">PMC6811497</ArticleId><ArticleId IdType="pubmed">31680811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Ban J-J, Kim KY, et al. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun. 2016;479:434&#x2013;439. doi: 10.1016/j.bbrc.2016.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.069</ArticleId><ArticleId IdType="pubmed">27641665</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi S, Bonaconsa M, Scambi I, et al. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333&#x2013;343. doi: 10.1016/j.neuroscience.2013.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.05.034</ArticleId><ArticleId IdType="pubmed">23727509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Turano E, Scambi I, et al. ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. 2020;21(10):3651. doi: 10.3390/ijms21103651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103651</ArticleId><ArticleId IdType="pmc">PMC7279464</ArticleId><ArticleId IdType="pubmed">32455791</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>